A network meta-analysis of association between cardiometabolic risk factors and COVID-19 outcome severity
Description
CONCLUSIONS: Considering the high prevalence of cardiometabolic comorbidities and risk of all severe outcomes, patients with cardiometabolic comorbidities should be prioritized in vaccination and treatment development of COVID-19.